Publications by authors named "Renee J Robb"

Claim this Profile
I
IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease.
Andrea S Henden, Motoko Koyama, Renee J Robb, Adriana Forero, Rachel D Kuns

Blood· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.
Motoko Koyama, Pamela Mukhopadhyay, Iona S Schuster, Andrea S Henden, Jan Hülsdünker, Renee J Robb

Immunity· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recipient mucosal-associated invariant T cells control GVHD within the colon.
Antiopi Varelias, Mark D Bunting, Kate L Ormerod, Motoko Koyama, Stuart D Olver, Renee J Robb

J Clin Invest· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flt-3L Expansion of Recipient CD8α Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHD.
Kate A Markey, Rachel D Kuns, Daniel J Browne, Kate H Gartlan, Renee J Robb

Clin Cancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT.
Kate H Gartlan, Antiopi Varelias, Motoko Koyama, Renee J Robb, Kate A Markey

Blood Adv· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoting regulation via the inhibition of DNAM-1 after transplantation.
Motoko Koyama, Rachel D Kuns, Stuart D Olver, Katie E Lineburg, Mary Lor, Renee J Robb

Blood· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The where and when of T cell regulation in transplantation.
Fadi Issa, Renee J Robb, Kathryn J Wood

Trends Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets.
Kate A Markey, Motoko Koyama, Rachel D Kuns, Katie E Lineburg, Yana A Wilson, Renee J Robb

Blood· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interferon-dependent orchestration of innate and adaptive immunity after transplantation.
Renee J Robb, Geoffrey R Hill

Blood· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
Renee J Robb, Katie E Lineburg, Rachel D Kuns, Yana A Wilson, Neil C Raffelt

Blood· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease.
Motoko Koyama, Rachel D Kuns, Stuart D Olver, Neil C Raffelt, Yana A Wilson, Renee J Robb

Nat Med· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I-IFNs control GVHD and GVL responses after transplantation.
Renee J Robb, Ellen Kreijveld, Rachel D Kuns, Yana A Wilson, Stuart D Olver

Blood· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble lymphotoxin is an important effector molecule in GVHD and GVL.
Kate A Markey, Angela C Burman, Tatjana Banovic, Rachel D Kuns, Neil C Raffelt, Renee J Robb

Blood· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis